BioSig Technologies, Inc. STEX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$46.69M+89.0% | -$424.01M-2,621% | -$15.58M+23.5% | -$20.37M-624% | -$2.81M-156% | ||
| -$34.25M+14.7% | -$40.16M-768% | -$4.63M+76.7% | -$19.81M-569% | -$2.96M-157% | ||
| -$35.75M+14.1% | -$41.63M-581% | -$6.11M+70.0% | -$20.37M-582% | -$2.98M-152% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
